|
CN1862257A
|
|
HPLC analyzing method of Vanoomgcin unit
|
|
CN1931854A
|
|
Intermediate for synthesizing fasidotril and its synthesis use
|
|
CN1931855A
|
|
Compound 2-methylol-3-substituted phenyl propionic acid with optical activity and its resolving process
|
|
CN1931837A
|
|
Preparation process of cadotril
|
|
CN1931821A
|
|
Split the method for 2-methylol-3-phenylpropionic acid optical isomer
|
|
CN1931830A
|
|
Intermediate compound for preparing dextro cadotril and its preparation process and use
|
|
CN1931853A
|
|
Compound 2-methylol-3-substituted phenyl propionic acid and its prepn process and use
|
|
CN1887943A
|
|
Filming gel composition and its use
|
|
CN1772738A
|
|
Crystalline Alipiprazole and its prepn
|
|
CN1847263A
|
|
Protein from snake venom for preventing and treating pyemia
|
|
CN1847262A
|
|
One kind of protein and its use
|
|
CN1706812A
|
|
Prepn process of (1R, 2S)-(-)-ephedrine or its hydrochloride
|
|
CN1583714A
|
|
Preparation of [(S)-(-)-alpha-methylamino phenylketone]2.(2R,3R)-tartaric acid derivative
|
|
CN1493361A
|
|
Lipid nano-particle of glyceride behenate and its preparation method
|
|
CN1548421A
|
|
Tilmisartan salt and its prepn
|
|
CN1449796A
|
|
Capsule containing ginkgo leaf extract
|
|
CN1059526A
|
|
4-sulphur replacement-4-deoxidation-4 '-demethylated podophyllotoxin derivative is synthetic
|
